163 related articles for article (PubMed ID: 35859802)
1. Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study.
Ni BK; Cai JY; Wang XB; Lin Q; Zhang XN; Wu JH
Neuropsychiatr Dis Treat; 2022; 18():1441-1453. PubMed ID: 35859802
[TBL] [Abstract][Full Text] [Related]
2. Utility of serum nuclear factor erythroid 2-related factor 2 as a potential prognostic biomarker of severe traumatic brain injury in adults: A prospective cohort study.
Yan XJ; Zhan CP; Lv Y; Mao DD; Zhou RC; Xv YM; Yu GF
Front Neurol; 2022; 13():1013062. PubMed ID: 36388174
[TBL] [Abstract][Full Text] [Related]
3. A prospective observational study on utility of serum mesencephalic astrocyte-derived neurotrophic factor as a promising prognostic biomarker of severe traumatic brain injury in humans.
Wang KW; Zhan CP; Liu YQ; Fu ZZ; Qiu TW; Yu GF
Clin Chim Acta; 2023 May; 545():117370. PubMed ID: 37137461
[TBL] [Abstract][Full Text] [Related]
4. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Serum Soluble Tim-3 in Severe Traumatic Brain Injury: A Prospective Observational Study.
Zhang H; Lv QW; Zheng ZQ; Shen LJ; Zhou J; Guo M
Neuropsychiatr Dis Treat; 2023; 19():153-169. PubMed ID: 36698699
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Serum NLRC4 as a Potential Prognostic Biochemical Marker in Humans with Severe Traumatic Brain Injury: A Prospective Cohort Study.
Tang B; Zhong Z; Wu J; Ma J; Li L; Zhong X; Lin D; Hu J; Yu P
Risk Manag Healthc Policy; 2023; 16():439-454. PubMed ID: 36994425
[TBL] [Abstract][Full Text] [Related]
7. Serum NOX4 as a Promising Prognostic Biomarker in Association with 90-Day Outcome of Severe Traumatic Brain Injury.
Jiang F; Chen Z; Hu J; Liu Q
Int J Gen Med; 2022; 15():5307-5317. PubMed ID: 35669593
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum annexin A7 in severe traumatic brain injury: A prospective longitudinal cohort study.
Zhao YY; Xu Y; Yang KC; Wang HB
Clin Chim Acta; 2022 Oct; 535():46-52. PubMed ID: 35985500
[TBL] [Abstract][Full Text] [Related]
9. [GCS score combined with CT score and serum S100B protein level Can evaluate severity and early prognosis of acute traumatic brain injury].
Yin W; Weng S; Lai S; Nie H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):543-548. PubMed ID: 33963713
[TBL] [Abstract][Full Text] [Related]
10. Performance of plasma von Willebrand factor in acute traumatic brain injury: relations to severity, CT findings, and outcomes.
Zeng R; Li S; Yu J; Ma H; Zhao Y
Front Neurosci; 2023; 17():1222345. PubMed ID: 38075262
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Longitudinal Cohort Study of Serum Stanniocalcin-1 as a Potential Prognostic Biomarker of Severe Traumatic Brain Injury.
Jin C; Huang X; Hu Y; Xu B; Ma J
Ther Clin Risk Manag; 2024; 20():341-361. PubMed ID: 38884106
[TBL] [Abstract][Full Text] [Related]
12. Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis.
Yan XJ; Li YB; Liu W; Wu HY; Yu GF
Neuropsychiatr Dis Treat; 2022; 18():47-55. PubMed ID: 35035218
[TBL] [Abstract][Full Text] [Related]
13. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in Rotterdam CT scores related to outcomes for patients with traumatic brain injury who undergo decompressive craniectomy.
Fujimoto K; Miura M; Otsuka T; Kuratsu J
J Neurosurg; 2016 Jun; 124(6):1640-5. PubMed ID: 26495949
[TBL] [Abstract][Full Text] [Related]
15. Serum netrin-1 as a potential biomarker for functional outcome of traumatic brain injury.
Xie Y; Guo Z; Chen F; Xiao C; Xu J; Bo D
Clin Chim Acta; 2021 Jul; 518():22-27. PubMed ID: 33741358
[TBL] [Abstract][Full Text] [Related]
16. Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings.
Rundhaug NP; Moen KG; Skandsen T; Schirmer-Mikalsen K; Lund SB; Hara S; Vik A
J Neurosurg; 2015 Jan; 122(1):211-8. PubMed ID: 25361494
[TBL] [Abstract][Full Text] [Related]
17. Temporal change of serum xanthine oxidase levels and its relation to clinical outcome of severe traumatic brain injury: a prospective cohort study.
Yan T; Shan H; Wang Z; Zou S; Chen Z; Yu W; Du Q; Dong X
Neurosurg Rev; 2023 Dec; 46(1):320. PubMed ID: 38038775
[TBL] [Abstract][Full Text] [Related]
18. Serum Gas6 contributes to clinical outcome after aneurysmal subarachnoid hemorrhage: A prospective cohort study.
Zhang X; Hong H; Wang X; Xie Q; Miao L; Zhang L
Clin Chim Acta; 2022 Aug; 533():96-103. PubMed ID: 35752306
[TBL] [Abstract][Full Text] [Related]
19. Serum sulfonylurea receptor-1 as a biomarker of clinical severity and prognosis in patients with traumatic brain injury.
Ying X; Chen M; Zhang J; Sun CF; Zhou J
Clin Chim Acta; 2022 Mar; 528():65-73. PubMed ID: 35092725
[TBL] [Abstract][Full Text] [Related]
20. Prediction of In-Hospital Mortality in Patients With Traumatic Brain Injury Using the Rotterdam and Marshall CT Scores: A Retrospective Study From Western India.
Goswami B; Nanda V; Kataria S; Kataria D
Cureus; 2023 Jul; 15(7):e41548. PubMed ID: 37554592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
